Works matching IS 03065251 AND DT 2012 AND VI 74 AND IP 3


Results: 19
    1
    2

    Cardiovascular risk.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 74, n. 3, p. 396, doi. 10.1111/j.1365-2125.2012.04219.x
    By:
    • Payne, Rupert A.
    Publication type:
    Article
    3
    4
    5
    6

    The pharmacokinetics of oxypurinol in people with gout.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 74, n. 3, p. 477, doi. 10.1111/j.1365-2125.2012.04207.x
    By:
    • Stocker, Sophie L.;
    • McLachlan, Andrew J.;
    • Savic, Radojka M.;
    • Kirkpatrick, Carl M.;
    • Graham, Garry G.;
    • Williams, Kenneth M.;
    • Day, Richard O.
    Publication type:
    Article
    7
    8
    9
    10

    Translation Section.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 74, n. 3, p. 551, doi. 10.1111/j.1365-2125.2012.04396.x
    Publication type:
    Article
    11
    12

    QRISK or Framingham?

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 74, n. 3, p. 545, doi. 10.1111/j.1365-2125.2012.04293.x
    By:
    • Robson, John;
    • Hippisley-Cox, Julia;
    • Coupland, Carol
    Publication type:
    Article
    13
    14
    15

    Drugs and the skin: psoriasis.

    Published in:
    British Journal of Clinical Pharmacology, 2012, v. 74, n. 3, p. 393, doi. 10.1111/j.1365-2125.2012.04380.x
    By:
    • Ritter, James M.
    Publication type:
    Article
    16
    17
    18
    19